Search Results 1-10 of 10950 for SC

  1. A Study of SC-007 in Subjects With Advanced Cancer - Mayo Clinic

    This is a multicenter, open-label, Phase 1 study in participants with colorectal cancer (CRC) or gastric cancer to study the safety and tolerability of SC ...

  2. Study of SC-003 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer - Mayo Clinic

    SC-003 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody linked to a potent chemotherapy. Participation eligibility. Participant ...

  3. SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM - Mayo Clinic

    About this study. The purpose of this study is to demonstrate the efficacy non-inferiority between isatuximab SC and isatuximab IV in combination with ...

  4. Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy - Mayo Clinic

    Secondary objectives include efficacy measures of efgartigimod PH20 SC in participants with IIM. IIM is a disease of the immune system that causes weakness of ...

  5. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

    About this study. This is a multicenter, open-label, Phase 1 study in participants with colorectal cancer (CRC), and consists of Part A (dose regimen ...

  6. Michael Camilleri, M.D., D.Sc. - Mayo Clinic Faculty Profiles

    Focus areas · Diabetic gastroparesis. Dr. · Obesity. Dr. · Irritable bowel syndrome and chronic constipation. These conditions account for 25 percent of all ...

  7. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

    Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult ...

  8. Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease - Mayo Clinic

    The purpose of this study is to assess the effect of vedolizumab subcutaneous (vedolizumab SC) as maintenance treatment in participants with moderately to ...

  9. A Study of SC‑004 in Subjects With Advanced Solid Tumors - Mayo Clinic

    In Part B (dose expansion), potential therapeutic doses may be studied with SC-004 as monotherapy and SC-004 in combination with ABBV-181 in disease-specific ...

  10. Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork Needle - Mayo Clinic

    Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork Needle · Overview · Participation eligibility · Participating Mayo Clinic locations.